$8.02
2.30% yesterday
Nasdaq, Aug 12, 10:00 pm CET
ISIN
KYG596651029
Symbol
MGTX

MeiraGTx Holdings plc Stock price

$8.02
-0.87 9.79% 1M
+1.58 24.53% 6M
+1.93 31.69% YTD
+4.02 100.50% 1Y
-3.23 28.71% 3Y
-6.21 43.64% 5Y
-6.98 46.53% 10Y
-6.98 46.53% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.18 2.30%
ISIN
KYG596651029
Symbol
MGTX
Industry

Key metrics

Basic
Market capitalization
$630.1m
Enterprise Value
$637.0m
Net debt
$7.0m
Cash
$66.5m
Shares outstanding
79.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
18.3 | 5.8
EV/Sales
18.5 | 5.8
EV/FCF
negative
P/B
19.0
Financial Health
Equity Ratio
25.1%
Return on Equity
-217.9%
ROCE
-92.7%
ROIC
-
Debt/Equity
2.2
Financials (TTM | estimate)
Revenue
$34.5m | $109.4m
EBITDA
$-146.4m | $111.8m
EBIT
$-159.0m | $-84.8m
Net Income
$-167.3m | $-64.6m
Free Cash Flow
$-109.6m
Growth (TTM | estimate)
Revenue
203.3% | 228.6%
EBITDA
-6.0% | 168.2%
EBIT
-4.6% | 48.4%
Net Income
-125.8% | 56.3%
Free Cash Flow
7.1%
Margin (TTM | estimate)
Gross
26.3%
EBITDA
-424.3% | 102.2%
EBIT
-460.9%
Net
-484.9% | -59.1%
Free Cash Flow
-317.5%
More
EPS
$-2.1
FCF per Share
$-1.4
Short interest
6.9%
Employees
378
Rev per Employee
$90.0k
Show more

Is MeiraGTx Holdings plc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

MeiraGTx Holdings plc Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a MeiraGTx Holdings plc forecast:

11x Buy
92%
1x Hold
8%

Analyst Opinions

12 Analysts have issued a MeiraGTx Holdings plc forecast:

Buy
92%
Hold
8%

Financial data from MeiraGTx Holdings plc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
35 35
203% 203%
100%
- Direct Costs 25 25
-
73%
9.06 9.06
-
26%
- Selling and Administrative Expenses 50 50
6% 6%
146%
- Research and Development Expense 118 118
2% 2%
342%
-146 -146
6% 6%
-424%
- Depreciation and Amortization 13 13
9% 9%
37%
EBIT (Operating Income) EBIT -159 -159
5% 5%
-461%
Net Profit -167 -167
126% 126%
-485%

In millions USD.

Don't miss a Thing! We will send you all news about MeiraGTx Holdings plc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MeiraGTx Holdings plc Stock News

Neutral
GlobeNewsWire
3 months ago
Multiple Poster Presentations Highlight the Depth and Novelty of MeiraGTx's Technology Platforms for Gene and Cell Therapy Multiple Poster Presentations Highlight the Depth and Novelty of MeiraGTx's Technology Platforms for Gene and Cell Therapy
Neutral
GlobeNewsWire
3 months ago
-  Announced strategic collaboration with Hologen AI, including a $200 million cash upfront payment to MeiraGTx and the formation of a joint venture, Hologen Neuro AI Ltd, with a further $230 million in capital committed to initially focus on expediting Phase 3 clinical development of AAV-GAD for Parkinson's disease -  U.S. Food and Drug Administration (FDA) Granted Regenerative Medicine Advanc...
Neutral
GlobeNewsWire
3 months ago
-  This RMAT designation is based on data from 3 clinical studies demonstrating the potential benefit of AAV-GAD as a one-time treatment for Parkinson's disease -  RMAT designation includes the benefits of the Fast Track and Breakthrough Therapy designations, allows frequent regulatory interactions with the FDA, and potential routes to accelerated approval and Priority Review LONDON and NEW YOR...
More MeiraGTx Holdings plc News

Company Profile

MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1 and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.

Head office Cayman Islands
CEO Alexandria Forbes
Employees 378
Founded 2015
Website meiragtx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today